2025 Conference
28th European GERPAC Conference
October 1, 2 & 3, 2025 - Hyères - France
In this space, you will find all the congress communications including conferences, round table, short oral communications and poster presentations.
Access to all communications requires that you are up to date with your annual GERPAC membership.
Opening of the conference
Concurrent workshops
Workshop1: EU Guidance for safe management of hazardous medicinal products at work
Dr Birgit Tans, University Hospitals Leuven - Belgium
Dr Paul Sessink, Exposure Control, Bjökö - Sweden
Workshop2: Managing Extractables and Leachables in Hospital Pharmacy Practices: Challenges and Insights
Dr Philip Chennel (Clermont-Ferrand - FR)
Dr Laurent Carrez, Dr William BELLO (Lausanne - CH)
Workshop 3: Microbiological environmental monitoring
Dr Fréderic Marçon (Amiens - FR)
Dr Thomas Storme (Vannes – FR)
Workshop 4: Designing a Centralized Cytotoxic Preparation Unit (CPU) to Minimize Musculoskeletal Disorders (MSDs)
Dr Anne Brouard-Le Bihan, Virginie Charbonneau, Jérémie Gautreau (Lorient - FR)
Dr Laurence Escalup, (Paris - FR)
Dr Marie-Noëlle Guerrault-Moro (Poissy-St Germain - FR)
Workshop 5: Training in the management of cytotoxic breakage through simulation: a team challenge
Dr Alexandra Garnier (CH) University Hospital Geneva / Dr Lucie Bouchoud (CH) University Hospital Geneva
Pharmaceutical issues and compounding in New Zealand for paedriatrics
Moderators
Dr D. Lannoy (Lille - France)
Dr F. Marçon (Amiens - France)
Pediatric Pharmaceutical Preparations in New Zealand: Applications and Problems.
Dr E. Oliphant (University of Auckland - New Zealand))
Eco-Conception in pharmaceutical technologies
Toward standardisation: Parenteral Nutrition in neonatology
Southern Pacific Approach
Dr Elizabeth OLIPHANT (School of Pharmacy University of Auckland - New Zealand)
French National Approach - The history of the 12 standards
Dr Thierry QUESSADA (Lyon - FR)
News from European working groups
Real’HOPE project
Dr M. Paulsson (Uppsala Univ. Hospital - Sweden)
GERPAC Special Interest Groups
Dr P. Le Brun (The Hague - Pays-Bas)
Pr I. Krämer (Mayence - Allemagne)
Artificial Intelligence (AI) in Hospital Pharmacy and its applications to pharmaceutical manufacturing
AI: What Is It Really?
Dr Aziza MERZOUKI (Geneva - CH)
Contributions of artificial intelligence to hospital pharmacy
Prof Frédéric Lagarce (Angers - FR)
Dr Frédéric Marçon (Amiens - FR)
Short oral communications
Can we limit our impact on the planet while producing chemotherapies?
A. Narwa, N. Raimundo, M. Lac, A. Merou, M. Soutera, P. Jeanselme, T. Goupil, S. Ennebet, S. Ribeiro, A. Martel, S. Perriat, F. Puisset, J.-M. Canonge
Pharmacy, IUCT Oncopole, France
Integrating an automated compounding system into an isolator: the relevance of microbiological requalification
C. Dréano, M. Delamotte, A. Lebreton, S. Crauste-Manciet
Pharmacy, CHU d’Angers, 4 rue Larrey, 49100 Angers, France
Evaluating microbial viability differently: impedance cytometry versus culture
R. Sintes1, M. Ehming2, S. Delage1, S. Luce2, Y. Roukoz-Diab2, F. Barbut2, A-C. Joly1
1 Pharmacie, Hôpital Saint-Antoine, APHP, Paris, France
2 Centre National de Référence Clostridioides difficile, Hôpital Saint-Antoine, APHP, Paris, France
French national external quality assessment campaign for parenteral nutrition controls
E. Kaczmar1, I. Soulairol2, T. Storme3, A. Venet4, P. Chennell5, R. Mazet6, External Quality Assessment Group of Hospital Control Laboratories7, C. Merienne1
1 Hospices Civils de Lyon, Edouard Herriot Hospital, Pharmacotechnics Unit, Lyon, France
2 Nîmes University Hospital, Pharmacy Department, Nîmes, France
3 APHP, Robert Debré Hospital, Pharmacy Department, Paris, France
4 Bordeaux University Hospital, Pharmacy Department, Bordeaux, France
5 Clermont-Ferrand University Hospital, University Clermont Auvergne, Clermont-Ferrand, France
6 Grenoble University Hospital, Pharmacy Department, Grenoble, France
7 APHP Cochin, APHP Debré, APHP Trousseau, Valenciennes Hospital, Poissy Saint Germain en Laye Intercommunal Hospital, Amiens University Hospital, Bordeaux University Hospital, Clermont-Ferrand University Hospital, Grenoble University Hospital, Limoges University Hospital, Martinique University Hospital, Mayotte University Hospital, Nancy University Hospital, Nantes University Hospital, Rennes University Hospital, Saint Etienne University Hospital, Toulouse University Hospital, Nice University Hospital, Tours University Hospital, Hospices Civils de Lyon (GHC and GHE)
Formulation of a Cyclodextrin-Based Ophthalmic Drug Solution of Chlorhexidine for the treatment of Acanthamoeba
S. Rigaud1,2, D. Mathiron1, F. Pilard2, F. Marçon3,4
1 Université de Picardie Jules Verne, Plateforme Analytique, Amiens, France
2 Université de Picardie Jules Verne, LG2A UR 7378, Amiens, France
3 Université de Picardie Jules Verne, AGIR UR 4294, Amiens, France
1,2 Centre Hospitalier Universitaire, Amiens, France
Feasibility study of an oral formulation of pyridoxine in the treatment of pharmacoresistant epilepsies
L. Hatte2, C. Danel2 , L. Négrier1,2, L. Pacqueu1 M. Vasseur1,2, A. Leleux1, M. Bouchfaa 1,2, P. Odou1,2
1 CHU Lille, institut de pharmacie, 59000 Lille, France
2 Université de Lille, CHU Lille, ULR 7365 - GRITA - Groupe de recherche sur les formes injectables et les technologies associées, 59000 Lille, France.
What is the future of Fused Deposition Modeling 3D printing in hospital pharmacies for the production of oral solid dosage forms ?
A. Lechanteur, C. Parulski, Q. Bourcy, O. Jennotte, R. Crunenberg, B. Evrard
Laboratory of Pharmaceutical Technology and Biopharmacy (LTPB), CIRM, Department of Pharmacy, University of Liège, Belgium
Evaluation of the impact of formulations and preparation conditions of reconstituted pemetrexed (PEME) specialties on its stability in infusion bags
L. Nobilet1, P.-H. Secretan2, A. Solgadi3, A. Hu1, A. Ouati1, D. Combeau1, M. Antignac1, H. Sadou Yayé1
1 Pharmacie, AP-HP Sorbonne Université Groupe Hospitalier Pitié Salpêtrière, Paris, France
2 Matériaux et santé, Université Paris-Saclay, Orsay, France
3 UMS-IPSIT SAMM Facility, Université Paris-Saclay, Inserm, CNRS, Ingénierie et Plateformes au Service de l’Innovation Thérapeutique, Orsay, France
Licensed ready-to-use gemcitabine bags cut carbon emissions versus in-house vial compounding
D. Protzenko, A. Plan
Pharmacie à Usage Intérieur, Centre Hospitalier Intercommunal des Alpes du Sud, 1 place Auguste Muret, 05000 Gap, France
Polyethersulfone in-line filters: an extractible study in the context of chemotherapy administration
A. Hassan1, J. Pinguet1, M. Barrieu2, M. Yessaad1, Y. Le Basle2, J. Claves1, V. Sautou2, P. Chennell2
1 CHU Clermont-Ferrand, Pôle Pharmacie, F-63003 Clermont-Ferrand, France
2 Université Clermont Auvergne, CHU Clermont Ferrand, Clermont Auvergne INP, CNRS, ICCF, F-63000 Clermont-Ferrand, France
One-year assessment of microbiological and particulate environnemental monitoring of equipment in a new radiopharmaceutical compounding unit
J. Le Galloudec, Y. Mortaki, C. Lucenay, V. Labeau, S. Camensuli, S. Ruster, A. Ramos, N. Rizzo Padoin
Centre Hospitalier Universitaire de Martinique, France
Feasibility study of a cardioplegia solution using the Del Nido formulation
L. Métreau, P. Marchadour, A. Schweitzer-Chaput, R. Ratiney, C. Cotteret, C. Gons
Service Pharmacie, Hôpital Necker-Enfants Malades, APHP, Université Paris-Cité, Paris, France
Innovative formulation of Cyclophosphamide chewable gummies, produced using 3D Printing, for pediatric administration
M. Boucida1 ; S. Ramos1 ; G. Chabrelle1 ; M. Vignes1 ; F-X Legrand2 ; B. Do1 ; M. Annereau1
1 Gustave Roussy, Villejuif, France
2 Institut Galien Paris-Saclay, Orsay, France
Mapping of sterile anticancer drug preparations in hospital pharmacies in Nouvelle-Aquitaine: current status, territorial disparities and opportunities for cooperation
N. Hami1,2, J. Azard2
1 Université de Bordeaux, 33000 Bordeaux, France
2 ARS Nouvelle-Aquitaine, Pôle Produits de santé, Pharmacie, Biologie, 33000 Bordeaux, France
USP-NF packaging system suitability: a simple yet powerful tool for differentiating packaging performances in terms of water permeability
A. Sury1, F. Marçon1,2
1 Centre Hospitalier Universitaire d’Amiens, Amiens, France
2 Université de Picardie Jules Verne, Laboratoire AGIR UR4294, Amiens, France
Development of a method for the quantification of bacterial endotoxins in parenteral vitamin-lipid emulsion preparations using the recombinant C factor
O. Allard1, M. Barrieu2, J. Claves1, M. Jouannet1, P. Chennell2
1 CHU Clermont-Ferrand, Pôle Pharmacie, F-63003 Clermont-Ferrand, France
2 Université Clermont Auvergne, CHU Clermont Ferrand, Clermont Auvergne INP, CNRS, ICCF, F-63000 Clermont-Ferrand, France
E-Posters - Session A: Quality Assurance, Risk Analysis and CSR
Implementation of a Professional Practice Assessment within a nuclear pharmacy
E. De Landtsheer, G. Pariscoat, J. Legrand
APHP, Hôpital Bichat Claude-Bernard, Paris, France
Evaluation of a reception and thawing assistance tool for securing the Car-t Cells circuit
C. Notteau1, L. Deramoudt1,2, M. Leroy1 ,A. Lecoutre1, J. Courtin1, M. Pinturaud1,2, M. Vasseur1,2, P. Odou1,2
1 Institut de Pharmacie, Centre Hospitalier Universitaire, Lille, France
2 Univ Lille, ULR 7365-GRITA, Lille, France
Reducing the air flow in a Chemotherapy Production Unit (CPU) during a period of rest without compromising environmental parameters during the activity in an eco- responsible approach.
A. Le Gall, A. Glavieux, C. Melin
Centre Hospitalier de Périgueux, France
Preliminary Risk Assessment of the Design of Facilities for the Preparation of Advanced Therapy Medicinal Products
G. Ayari, N. Nicolas, C. Vallance
Institut de Cancérologie de Lorraine - Alexis Vautrin, Vandœuvre-lès-Nancy, France
Non-sterile preparations: how to assess occupational risk for pharmacy technicians ?
P. Bouquet, C. Lamour, V. Vincourt, A. Podvin
Centre Hospitalier de Douai, France
Implementation of Datamatrix Codes on Vials: A Time-Saving Measure?
M. Lac, A. Narwa, N. Raimundo, A. Merou, M. Soutera, P. Jeanselme, K. Leger, O. Civier, S. Ennebet, C. Guillemot, F. Puisset, S. Perriat, A. Martel
Pharmacy Department, IUCT Oncopole
Conception and Evaluation of a regional tool for risk situations of errors or exposure related to the use of cytotoxics
Z. Mellahi1, V. Massot1, Z. Leguay2, H. Du Portal3
1 Centre Hospitalier Régional Universitaire de Tours, France
2 Centre Hospitalier Universitaire d’Orléans, France
3 OMéDIT Centre-Val de Loire, Tours, France
Qualification of Pharmaceutical Staff for Handling Cytotoxic Safety Cabinets: Simulation at the Heart of Certification
L. Fourcaud, S. Hermann, G. Hily, D. Sankhare, N. Jourdan, I. Madelaine, M. Brault
Hôpital Saint-Louis (APHP), Paris, France
Continuing education of hospital pharmacy technicians in Cytotoxic Reconstitution Unit (CRU) a regional level answer: results of 4 CRUATHLON
H. Bertucat1, L. Cantournet2, R. Chevrier3, A-C. Cholley4, S. Danjean5, A. Demaziere1, M. Etis6, M. Jouannet7, C. Lechevalier8, A. Peyrol9, S. Picandet10, S. Talavera-Pons11, S. Trevis7, C. Ragazzon12, A. Simand13, E. Sigward14
1 CH J. Lacarin Vichy, 2 CH Henri Mondor Aurillac, 3 Centre Jean Perrin Clermont Ferrand, 4 CH de Brioude, 5 CH de Moulins-Yzeure, 6 CH de Roanne, 7 CHU Clermont Ferrand, 8 CH de St-Flour, 9 CH d’Ambert, 10 Clinique St Francois Désertines, 11 CH de Thiers, 12 CH Emile Roux Puy en Velay, 13 Pole Santé République Clermont Ferrand, 14 CH de Montluçon, France.
Prospective Assessment of the Economic Implications of Automating Chemotherapy Preparation in a Comprehensive Cancer Center
A. Maes, C. Mennetrier, S. Capron, F. Basuyau, J. Rouvet
Centre Henri Becquerel, Rouen, France
“Save Patient B”. An Escape Game in a Cytotoxic Production Unit"
J. Palluaud, C. Buet, M. Benmalek, L. Pagnot, B. Cortes, E. Dussossoy
Hospices Civils de Lyon, Groupement Hospitalier Nord, Hôpital de la Croix-Rousse, France
E-Posters - Session B: Feasibility studies - Formulations
Optimization of the production of Gallium-68 labeled peptides (PSMA et DOTATOC)
J. Costes1, A. Pierrot1, K. Casagrande1, J. Masset2, J. Delage1, F. Sadeghipour1,3,4.
1 Pharmacy Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
2 Research and Development Center, Trasis Radiopharmacy Instruments, Ans, Belgium.
3 Pharmaceutical Sciences, Geneva-Lausanne Pharmacy School, University of Geneva, Switzerland.
4 Centre de Recherche et d’Innovations en Sciences Pharmaceutiques cliniques, University of Lausanne, Switzerland.
Technical and regulatory feasibility of a new sterile preparation posing health and environmental risk: the case of 30% ethanol eye drops
A-L. Dupart, C. De Lacroix, O. Foulon, G. Camus, A-L. Antoine
Pharmacie à usage intérieur, Hôpital national d’instruction des armées Percy, Clamart, France
Feasibility study: internal production and controls of autologous serum eyedrops (ASED)
D. Clerice, L. Jemour, I. Girault, H. Perrier
Centre Hospitalier du Mans, Le Mans, France
Development of an automatized production of 68Ga-FAPI-46 in an Hospital
A. Pierrot1, K. Casagrande1, J. Costes1, J. Delage1, F. Sadeghipour2,3,4
1 Radiopharmacy Unit, Department of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, SWITZERLAND,
2 Department of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, SWITZERLAND,
3 Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, SWITZERLAND,
4 Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Lausanne, SWITZERLAND.
Feasibility study of centralizing biotherapy preparations at the Annecy Genevois Hospital Center
R. Francis, C. Zecchini Prina, P. Lourman, G. Vary
PUI, Annecy Genevois Hospital Center
Flocculation of etoposide preparations: what are the influencing factors?
C. Martelet1, C. Lopes1, E.Baba1, L. Negrier1,2 C. Danel1, J. Courtin1, A. Lecoutre1, M. Vasseur1,2, P. Odou1,2
1 CHU Lille, Institut de pharmacie, 59000 Lille, France
2 Université de Lille, CHU Lille, ULR 7365 - GRITA - Groupe de recherche sur les formes injectables et les technologies associées, 59000 LILLE
Development of a new formulation for preparing oral provocation tests (OPT) for nuts in allergology
J. Lahsinat, J. Bourbon, S. Doucet
Hôpitaux Civils de Colmar, France
Identification of critical parameters for an automatic film applicator to produce orodispersible hydrocortisone hemisuccinate films
L. Nobilet1, B. Toussaint1,2, M. Sauvat1, A. Thouvenin1,2, B. Andre-Nonque1, P. Lamarque3, E. De Landtsheer3, A. Schweitzer-Chaput3, V. Boudy1,2
1 Département de Recherche et Développement Pharmaceutique, AGEPS, APHP, Paris, France
2 UTCBS, CNRS, Inserm, Université Paris Cité, Paris, France
3 Pharmacie à Usage Intérieur, Hôpital Necker-Enfants Malades, APHP, Paris, France
3D Printing of Antiemetics: Rheology Serving Personalized Medicine
R. Bodin, S. Ramos, M. Boucida, L. Denis, B. Do
Gustave Roussy, Villejuif, France
Qualification of the aseptic process for preparing 10%-5% glycerol-fructose bags
Qualification of the aseptic process for preparing 10%-5% glycerol-fructose bags
A. Megnounif, C. Baguet, P. Chapron, E. Olivier, N. Cormier
Pharmacie, Nantes Université, CHU, Nantes, France
E-Posters - Session C: Stability studies and quality control
Training and qualification in the visual inspection and labelling of hospital-compounded eye drops
J. Prud’homme, H. Briche, A. Kalinowski, M.-L. Brandely-Piat, M. Jobard, R. Batista
APHP, Hôpital Cochin, Paris, France
Case of non-compliant eye drops: investigation on non visible particles
E. Tireau, K. Lefevre, V. Lebreton, S. Vrignaud
Centre Hospitalier Universitaire Angers, France
Container-content interactions tests for automated dispensing of radiopharmaceuticals : who’s gonna stick to it?
M. Delion, R. Boquet, C. Schmitt, O. Madar, J. Fouque
Institut Curie, Saint Cloud, France
Sterility testing of aqueous and oily eye drops using the Bactec® automated system: feasibility and validation
C. Ankidine, L. Bourgue, Y.-P. Yemi, M. Ben Reguiga
Centre Hospitalier de Mayotte, France
Paclitaxel desensitization protocol: stability study
C. Mathieu1, A. Pinard1,2, F. Pham1, H. Doillet1, S. Poullain1
1 Centre Hospitalier Intercommunal de Créteil, France
2 APHP, Hôpital Henri Mondor, Créteil, France
Physico-chemical stability of ceftazidime fortified eye drops 20 mg/mL stored at -20°C
G. Loeuille, S. Brafine, M. Paulin, K. Nasraoui, S. Ruster, C. Padoin
University Hospital of Martinique, Fort-de-France, France
Stability study of several insulins in a binary parenteral nutrition mixture.
T. Ternel1,2, C. Foulon1, M. Kouach1, T. Dine1, H. Henry1,2, P. Odou1,2
1 Univ. Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France
2 CHU Lille, Institut de pharmacie, F-59000 Lille, France
Comparative Study of Content Uniformity Between Capsules and 3D-Printed Oral Forms Manufactured by Semi-Solid Extrusion
L. Lemierrea,b, D. Stefanellia, S. Roulona, R. Mazet c, C. Curti d, I. Soulairola,b,e
a MB Therapeutics, Montpellier, France
b ICGM, University of Montpellier, CNRS, ENSCM, Montpellier, France
c Pharmacy Department, CHU Grenoble Alpes, Grenoble, France
d Pharmacy Department, APHM, Marseille, France
e Pharmacy Department, CHU de Nîmes, Nîmes, France
Implementation of a protocol to induce tolerance to nirogacestat in a responder patient: stability of a drinkable liquid form
O. Nowak1, A. Lavergne1, C. Coumes-Salomon2, V. Le-Brun-Ly2, S. Dulaurent2, N. Picard2, V. Ratsimbazafy2
1 Université de Pharmacie de Limoges, France
2 Centre Hospitalier Universitaire de Limoges, France
Microbiological stability of a 10 µg/mL clonidine solution for paediatric use
C. Ranza, C. Fanjeaux, R. Vazquez, M-N. Guerrault-Moro
Centre Hospitalier Intercommunal de Poissy St-Germain-en-Laye, France
E-Posters - Session D: Production and automation processes
No safety net in pharmaceutical technology: How the absence of continuous service affects hospital practice?
G. Baroux, A. Jalabert, A. Quintard, M. Cosson
Centre Hospitalier Universitaire de Montpellier, France
Optimization of repackaging practices for solid oral forms
M. Vicart, C. Senis loiseau, M. Khadimallah, C. Gransard, C. Floret
Centre Hospitalier de Béthune Beuvry, France
Continuity of cancer treatment preparation : what resources are available at the regional level?
C. Miniot1, H. Brillard2, C. Le Deroff-Poupeau1, N. Cassou2
1 OMEDIT Bretagne, Quimper, France
2 Pharmacie à Usage Intérieur, CH de Cornouaille, Quimper, France
Cytotoxic drugs on the loose: alert, prevention, action!
C. Morel, S. Muhammad, A. Brian, F. Bordet, M.-L. Maëstroni
Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France
Robustness Evaluation of a Semi-Solid Extrusion 3D Printing Process for Oral Dosage Forms: A Case Study with Melatonin
L. Lemierre1,2 , D. Stefanelli1 , S. Roulon1 , I. Soulairol1,2,3
1 MB Therapeutics, Montpellier, France
2 ICGM, Université de Montpellier, CNRS, ENSCM, Montpellier, France
3 Département de pharmacie, CHU de Nîmes, Nîmes, France
Qualification of Biocleaning in Cleanrooms
L. Ciarlitti1, M. Cristofoli1, N. Malié, 1A. Bensahkoun1, C. Marchand1, B. Lapras1, C. Merienne1, F. Pirot1,2
1 Hospices Civils de Lyon, Groupement Hospitalier Edouard Herriot, Lyon, France
2 Université Claude Bernard Lyon-1, Faculté de Pharmacie de Lyon, Laboratoire de Biologie tissulaire et Ingénierie Thérapeutique UMR-CNRS 5305, France
Validation of an automated method for cyclophosphamide reconstitution and comparison with the manual process
E. Roulleau, B. Mathat, E. Clapeau, A. Goubil, C. Fronteau, V. Laurent, C. Baguet, N. Cormier
Pharmacy unit, University Hospital of Nantes, France
Gallium radioactive labelling using radionuclide generators from different suppliers
T. Bataillard, L. Cougourdan, E. Mordefroy, O. Angoue
Centre Hospitalier Universitaire Jean Minjoz, Besançon, France
Microbiological qualification of a robot, Kiro Isolator® (Grifols), for the preparation of anticancer chemotherapies
J. Guehenneux, A. Delépine, R. Desmaris, M. Friou
Institut Curie, Saint-Cloud, France
One ATMP, Two Hospital Pharmacies, No Compromise
A. Barusseau1, A. Brun-Fitton1, A. Brouard1, B. Quélennec1, M.-A. Lester2, A. Jouvance-Le Bail2, A. Chérel1
1 : Service Pharmacie, Groupe Hospitalier Bretagne Sud, 5 avenue de Choiseul, 56100 Lorient, France
2 : Pharmacie, CHU de Rennes, 2 Rue Henri Le Guilloux, 35000 Rennes, France
Cytotoxic Agents: Breaking to Manage Better!
C. Communier, F. Gaume, F. Ou Cebron, C. Airiau
Centre Hospitalier de Cholet, France
E-Posters - Session E: Analytical and microbiological techniques
Physicochemical Validation of the Sterile Filtration Process for Hospital-Compounded Gentamicin Eye Drops
G. Sayet, S. Bansart, V. Delplanque, M-G. Philipot, M-C. Despiau
Hôpital National de la vision, Paris, France
Validation of a stability-indicating assay method for epalrestat using UV detection high-performance liquid chromatography
V. Raffet, I. Palmieri, P. Marchadour, C. Cotteret, A. Schweitzer-Chaput
APHP, Hôpital Necker-Enfants Malades, Paris
Characterisation of polymer films for intravenous solvent bags packaging
C. Hosotte, L. Carrez, F. Sadeghipour
Centre Hospitalier Universitaire Vaudois, Lausanne, Suisse
Development of a gamma counter calibration protocol for radiopharmaceutical applications
E. Oger, L. Guiheneuc, M. Bourgeois
Centre Hospitalier Universitaire de Nantes, France
Method Development for the Quantification of Erythromycin in 250 mg Capsules
I. Palmieri, V. Raffet, P. Marchadour, R. Ratiney, C. Cotteret, A. Schweitzer-Chaput
Department of Pharmacy, AP-HP, Necker Hospital, Paris, France.
A blood gas analyzer for parenteral nutrition bags analysis? Performance evaluation and method validation
K. Tlili, N. Chaoui, A. Diallo, X. Deviot
Centre Hospitalier de Saint-Denis, France
Analytical Control by UV Spectrophotometry with DRUGLOG®: Relevance for In-House Calibration Ranges?
N. Salama, T. Tang, S. Belhadj, H. Smati, S. Blondeel-Gomes, L. Bisseux, F. El Kouari
Pharmacy Department, GHI Le Raincy-Montfermeil, France
Development and Validation of the Sterility Test for a New 1mg/mL Ropivacaine Preparation
C. Auriault, C. Baguet, P. Chapron, N. Humeau, F. Bellabiod, S. Guernier, E. Olivier, N. Cormier
Centre Hospitalier Universitaire de Nantes, France
Développement et validation de l’essai de stérilité pour une nouvelle préparation de ropivacaïne à 1 mg/mL
C. Auriault, C. Baguet, P. Chapron, N. Humeau, F. Bellabiod, S. Guernier, E. Olivier, N. Cormier
Centre Hospitalier Universitaire de Nantes, France
Development and Validation of the Sterility Test for a New 1mg/mL Ropivacaine Preparation
C. Auriault, C. Baguet, P. Chapron, N. Humeau, F. Bellabiod, S. Guernier, E. Olivier, N. Cormier
Centre Hospitalier Universitaire de Nantes, France
GERPAC
Association Loi 1901
Siège social : Chez Jean-Yves Jomier / 8ter rue Léon Bussat, 64000 PAU
Immatriculation formation N° 72 64 035 30 64
Contact us Legal notes - Management of personal data
28th European GERPAC Conference
October 1, 2 & 3, 2025 - Hyères - France
In this space, you will find all the congress communications including conferences, round table, short oral communications and poster presentations.
Opening of the conference
Concurrent workshops
Workshop1: EU Guidance for safe management of hazardous medicinal products at work
Dr Birgit Tans, University Hospitals Leuven - Belgium
Dr Paul Sessink, Exposure Control, Bjökö - Sweden
Workshop2: Managing Extractables and Leachables in Hospital Pharmacy Practices: Challenges and Insights Dr Philip Chennel (Clermont-Ferrand - FR)
Dr Laurent Carrez, Dr William BELLO (Lausanne - CH)
Workshop 3: Microbiological environmental monitoring Dr Fréderic Marçon (Amiens - FR)
Dr Thomas Storme (Vannes – FR)
Workshop 4: Designing a Centralized Cytotoxic Preparation Unit (CPU) to Minimize Musculoskeletal Disorders (MSDs) Dr Anne Brouard-Le Bihan, Virginie Charbonneau, Jérémie Gautreau (Lorient - FR)
Dr Laurence Escalup, (Paris - FR)
Dr Marie-Noëlle Guerrault-Moro (Poissy-St Germain - FR)
Workshop 5: Training in the management of cytotoxic breakage through simulation: a team challenge Dr Alexandra Garnier (CH) University Hospital Geneva / Dr Lucie Bouchoud (CH) University Hospital Geneva
Dr Paul Sessink, Exposure Control, Bjökö - Sweden
Workshop2: Managing Extractables and Leachables in Hospital Pharmacy Practices: Challenges and Insights Dr Philip Chennel (Clermont-Ferrand - FR)
Dr Laurent Carrez, Dr William BELLO (Lausanne - CH)
Workshop 3: Microbiological environmental monitoring Dr Fréderic Marçon (Amiens - FR)
Dr Thomas Storme (Vannes – FR)
Workshop 4: Designing a Centralized Cytotoxic Preparation Unit (CPU) to Minimize Musculoskeletal Disorders (MSDs) Dr Anne Brouard-Le Bihan, Virginie Charbonneau, Jérémie Gautreau (Lorient - FR)
Dr Laurence Escalup, (Paris - FR)
Dr Marie-Noëlle Guerrault-Moro (Poissy-St Germain - FR)
Workshop 5: Training in the management of cytotoxic breakage through simulation: a team challenge Dr Alexandra Garnier (CH) University Hospital Geneva / Dr Lucie Bouchoud (CH) University Hospital Geneva
Pharmaceutical issues and compounding in New Zealand for paedriatrics
Moderators
Dr D. Lannoy (Lille - France)Dr F. Marçon (Amiens - France)
Pediatric Pharmaceutical Preparations in New Zealand: Applications and Problems.
Dr E. Oliphant (University of Auckland - New Zealand))Eco-Conception in pharmaceutical technologies
Toward standardisation: Parenteral Nutrition in neonatology
Southern Pacific Approach
Dr Elizabeth OLIPHANT (School of Pharmacy University of Auckland - New Zealand)
French National Approach - The history of the 12 standards
Dr Thierry QUESSADA (Lyon - FR)
News from European working groups
Real’HOPE project
Dr M. Paulsson (Uppsala Univ. Hospital - Sweden)
GERPAC Special Interest Groups
Dr P. Le Brun (The Hague - Pays-Bas)
Pr I. Krämer (Mayence - Allemagne)
Pr I. Krämer (Mayence - Allemagne)
Artificial Intelligence (AI) in Hospital Pharmacy and its applications to pharmaceutical manufacturing
AI: What Is It Really?
Dr Aziza MERZOUKI (Geneva - CH)
Contributions of artificial intelligence to hospital pharmacy Prof Frédéric Lagarce (Angers - FR)
Dr Frédéric Marçon (Amiens - FR)
Contributions of artificial intelligence to hospital pharmacy Prof Frédéric Lagarce (Angers - FR)
Dr Frédéric Marçon (Amiens - FR)
Short oral communications
Can we limit our impact on the planet while producing chemotherapies?
A. Narwa, N. Raimundo, M. Lac, A. Merou, M. Soutera, P. Jeanselme, T. Goupil, S. Ennebet, S. Ribeiro, A. Martel, S. Perriat, F. Puisset, J.-M. Canonge
Pharmacy, IUCT Oncopole, France
Integrating an automated compounding system into an isolator: the relevance of microbiological requalification
C. Dréano, M. Delamotte, A. Lebreton, S. Crauste-Manciet
Pharmacy, CHU d’Angers, 4 rue Larrey, 49100 Angers, France
Evaluating microbial viability differently: impedance cytometry versus culture
R. Sintes1, M. Ehming2, S. Delage1, S. Luce2, Y. Roukoz-Diab2, F. Barbut2, A-C. Joly1
1 Pharmacie, Hôpital Saint-Antoine, APHP, Paris, France
2 Centre National de Référence Clostridioides difficile, Hôpital Saint-Antoine, APHP, Paris, France
French national external quality assessment campaign for parenteral nutrition controls
E. Kaczmar1, I. Soulairol2, T. Storme3, A. Venet4, P. Chennell5, R. Mazet6, External Quality Assessment Group of Hospital Control Laboratories7, C. Merienne1
1 Hospices Civils de Lyon, Edouard Herriot Hospital, Pharmacotechnics Unit, Lyon, France
2 Nîmes University Hospital, Pharmacy Department, Nîmes, France
3 APHP, Robert Debré Hospital, Pharmacy Department, Paris, France
4 Bordeaux University Hospital, Pharmacy Department, Bordeaux, France
5 Clermont-Ferrand University Hospital, University Clermont Auvergne, Clermont-Ferrand, France
6 Grenoble University Hospital, Pharmacy Department, Grenoble, France
7 APHP Cochin, APHP Debré, APHP Trousseau, Valenciennes Hospital, Poissy Saint Germain en Laye Intercommunal Hospital, Amiens University Hospital, Bordeaux University Hospital, Clermont-Ferrand University Hospital, Grenoble University Hospital, Limoges University Hospital, Martinique University Hospital, Mayotte University Hospital, Nancy University Hospital, Nantes University Hospital, Rennes University Hospital, Saint Etienne University Hospital, Toulouse University Hospital, Nice University Hospital, Tours University Hospital, Hospices Civils de Lyon (GHC and GHE)
Formulation of a Cyclodextrin-Based Ophthalmic Drug Solution of Chlorhexidine for the treatment of Acanthamoeba
S. Rigaud1,2, D. Mathiron1, F. Pilard2, F. Marçon3,4
1 Université de Picardie Jules Verne, Plateforme Analytique, Amiens, France
2 Université de Picardie Jules Verne, LG2A UR 7378, Amiens, France
3 Université de Picardie Jules Verne, AGIR UR 4294, Amiens, France
1,2 Centre Hospitalier Universitaire, Amiens, France
Feasibility study of an oral formulation of pyridoxine in the treatment of pharmacoresistant epilepsies
L. Hatte2, C. Danel2 , L. Négrier1,2, L. Pacqueu1 M. Vasseur1,2, A. Leleux1, M. Bouchfaa 1,2, P. Odou1,2
1 CHU Lille, institut de pharmacie, 59000 Lille, France
2 Université de Lille, CHU Lille, ULR 7365 - GRITA - Groupe de recherche sur les formes injectables et les technologies associées, 59000 Lille, France.
What is the future of Fused Deposition Modeling 3D printing in hospital pharmacies for the production of oral solid dosage forms ? A. Lechanteur, C. Parulski, Q. Bourcy, O. Jennotte, R. Crunenberg, B. Evrard
Laboratory of Pharmaceutical Technology and Biopharmacy (LTPB), CIRM, Department of Pharmacy, University of Liège, Belgium Evaluation of the impact of formulations and preparation conditions of reconstituted pemetrexed (PEME) specialties on its stability in infusion bags L. Nobilet1, P.-H. Secretan2, A. Solgadi3, A. Hu1, A. Ouati1, D. Combeau1, M. Antignac1, H. Sadou Yayé1
1 Pharmacie, AP-HP Sorbonne Université Groupe Hospitalier Pitié Salpêtrière, Paris, France
2 Matériaux et santé, Université Paris-Saclay, Orsay, France
3 UMS-IPSIT SAMM Facility, Université Paris-Saclay, Inserm, CNRS, Ingénierie et Plateformes au Service de l’Innovation Thérapeutique, Orsay, France Licensed ready-to-use gemcitabine bags cut carbon emissions versus in-house vial compounding D. Protzenko, A. Plan
Pharmacie à Usage Intérieur, Centre Hospitalier Intercommunal des Alpes du Sud, 1 place Auguste Muret, 05000 Gap, France Polyethersulfone in-line filters: an extractible study in the context of chemotherapy administration A. Hassan1, J. Pinguet1, M. Barrieu2, M. Yessaad1, Y. Le Basle2, J. Claves1, V. Sautou2, P. Chennell2
1 CHU Clermont-Ferrand, Pôle Pharmacie, F-63003 Clermont-Ferrand, France
2 Université Clermont Auvergne, CHU Clermont Ferrand, Clermont Auvergne INP, CNRS, ICCF, F-63000 Clermont-Ferrand, France One-year assessment of microbiological and particulate environnemental monitoring of equipment in a new radiopharmaceutical compounding unit J. Le Galloudec, Y. Mortaki, C. Lucenay, V. Labeau, S. Camensuli, S. Ruster, A. Ramos, N. Rizzo Padoin
Centre Hospitalier Universitaire de Martinique, France Feasibility study of a cardioplegia solution using the Del Nido formulation L. Métreau, P. Marchadour, A. Schweitzer-Chaput, R. Ratiney, C. Cotteret, C. Gons
Service Pharmacie, Hôpital Necker-Enfants Malades, APHP, Université Paris-Cité, Paris, France Innovative formulation of Cyclophosphamide chewable gummies, produced using 3D Printing, for pediatric administration M. Boucida1 ; S. Ramos1 ; G. Chabrelle1 ; M. Vignes1 ; F-X Legrand2 ; B. Do1 ; M. Annereau1
1 Gustave Roussy, Villejuif, France
2 Institut Galien Paris-Saclay, Orsay, France
Mapping of sterile anticancer drug preparations in hospital pharmacies in Nouvelle-Aquitaine: current status, territorial disparities and opportunities for cooperation N. Hami1,2, J. Azard2
1 Université de Bordeaux, 33000 Bordeaux, France
2 ARS Nouvelle-Aquitaine, Pôle Produits de santé, Pharmacie, Biologie, 33000 Bordeaux, France USP-NF packaging system suitability: a simple yet powerful tool for differentiating packaging performances in terms of water permeability A. Sury1, F. Marçon1,2
1 Centre Hospitalier Universitaire d’Amiens, Amiens, France
2 Université de Picardie Jules Verne, Laboratoire AGIR UR4294, Amiens, France
Development of a method for the quantification of bacterial endotoxins in parenteral vitamin-lipid emulsion preparations using the recombinant C factor O. Allard1, M. Barrieu2, J. Claves1, M. Jouannet1, P. Chennell2
1 CHU Clermont-Ferrand, Pôle Pharmacie, F-63003 Clermont-Ferrand, France
2 Université Clermont Auvergne, CHU Clermont Ferrand, Clermont Auvergne INP, CNRS, ICCF, F-63000 Clermont-Ferrand, France
Pharmacy, IUCT Oncopole, France
Integrating an automated compounding system into an isolator: the relevance of microbiological requalification
C. Dréano, M. Delamotte, A. Lebreton, S. Crauste-MancietPharmacy, CHU d’Angers, 4 rue Larrey, 49100 Angers, France
Evaluating microbial viability differently: impedance cytometry versus culture
R. Sintes1, M. Ehming2, S. Delage1, S. Luce2, Y. Roukoz-Diab2, F. Barbut2, A-C. Joly11 Pharmacie, Hôpital Saint-Antoine, APHP, Paris, France
2 Centre National de Référence Clostridioides difficile, Hôpital Saint-Antoine, APHP, Paris, France
French national external quality assessment campaign for parenteral nutrition controls
E. Kaczmar1, I. Soulairol2, T. Storme3, A. Venet4, P. Chennell5, R. Mazet6, External Quality Assessment Group of Hospital Control Laboratories7, C. Merienne11 Hospices Civils de Lyon, Edouard Herriot Hospital, Pharmacotechnics Unit, Lyon, France
2 Nîmes University Hospital, Pharmacy Department, Nîmes, France
3 APHP, Robert Debré Hospital, Pharmacy Department, Paris, France
4 Bordeaux University Hospital, Pharmacy Department, Bordeaux, France
5 Clermont-Ferrand University Hospital, University Clermont Auvergne, Clermont-Ferrand, France
6 Grenoble University Hospital, Pharmacy Department, Grenoble, France
7 APHP Cochin, APHP Debré, APHP Trousseau, Valenciennes Hospital, Poissy Saint Germain en Laye Intercommunal Hospital, Amiens University Hospital, Bordeaux University Hospital, Clermont-Ferrand University Hospital, Grenoble University Hospital, Limoges University Hospital, Martinique University Hospital, Mayotte University Hospital, Nancy University Hospital, Nantes University Hospital, Rennes University Hospital, Saint Etienne University Hospital, Toulouse University Hospital, Nice University Hospital, Tours University Hospital, Hospices Civils de Lyon (GHC and GHE)
Formulation of a Cyclodextrin-Based Ophthalmic Drug Solution of Chlorhexidine for the treatment of Acanthamoeba
S. Rigaud1,2, D. Mathiron1, F. Pilard2, F. Marçon3,41 Université de Picardie Jules Verne, Plateforme Analytique, Amiens, France
2 Université de Picardie Jules Verne, LG2A UR 7378, Amiens, France
3 Université de Picardie Jules Verne, AGIR UR 4294, Amiens, France
1,2 Centre Hospitalier Universitaire, Amiens, France
Feasibility study of an oral formulation of pyridoxine in the treatment of pharmacoresistant epilepsies
L. Hatte2, C. Danel2 , L. Négrier1,2, L. Pacqueu1 M. Vasseur1,2, A. Leleux1, M. Bouchfaa 1,2, P. Odou1,21 CHU Lille, institut de pharmacie, 59000 Lille, France
2 Université de Lille, CHU Lille, ULR 7365 - GRITA - Groupe de recherche sur les formes injectables et les technologies associées, 59000 Lille, France.
What is the future of Fused Deposition Modeling 3D printing in hospital pharmacies for the production of oral solid dosage forms ? A. Lechanteur, C. Parulski, Q. Bourcy, O. Jennotte, R. Crunenberg, B. Evrard
Laboratory of Pharmaceutical Technology and Biopharmacy (LTPB), CIRM, Department of Pharmacy, University of Liège, Belgium Evaluation of the impact of formulations and preparation conditions of reconstituted pemetrexed (PEME) specialties on its stability in infusion bags L. Nobilet1, P.-H. Secretan2, A. Solgadi3, A. Hu1, A. Ouati1, D. Combeau1, M. Antignac1, H. Sadou Yayé1
1 Pharmacie, AP-HP Sorbonne Université Groupe Hospitalier Pitié Salpêtrière, Paris, France
2 Matériaux et santé, Université Paris-Saclay, Orsay, France
3 UMS-IPSIT SAMM Facility, Université Paris-Saclay, Inserm, CNRS, Ingénierie et Plateformes au Service de l’Innovation Thérapeutique, Orsay, France Licensed ready-to-use gemcitabine bags cut carbon emissions versus in-house vial compounding D. Protzenko, A. Plan
Pharmacie à Usage Intérieur, Centre Hospitalier Intercommunal des Alpes du Sud, 1 place Auguste Muret, 05000 Gap, France Polyethersulfone in-line filters: an extractible study in the context of chemotherapy administration A. Hassan1, J. Pinguet1, M. Barrieu2, M. Yessaad1, Y. Le Basle2, J. Claves1, V. Sautou2, P. Chennell2
1 CHU Clermont-Ferrand, Pôle Pharmacie, F-63003 Clermont-Ferrand, France
2 Université Clermont Auvergne, CHU Clermont Ferrand, Clermont Auvergne INP, CNRS, ICCF, F-63000 Clermont-Ferrand, France One-year assessment of microbiological and particulate environnemental monitoring of equipment in a new radiopharmaceutical compounding unit J. Le Galloudec, Y. Mortaki, C. Lucenay, V. Labeau, S. Camensuli, S. Ruster, A. Ramos, N. Rizzo Padoin
Centre Hospitalier Universitaire de Martinique, France Feasibility study of a cardioplegia solution using the Del Nido formulation L. Métreau, P. Marchadour, A. Schweitzer-Chaput, R. Ratiney, C. Cotteret, C. Gons
Service Pharmacie, Hôpital Necker-Enfants Malades, APHP, Université Paris-Cité, Paris, France Innovative formulation of Cyclophosphamide chewable gummies, produced using 3D Printing, for pediatric administration M. Boucida1 ; S. Ramos1 ; G. Chabrelle1 ; M. Vignes1 ; F-X Legrand2 ; B. Do1 ; M. Annereau1
1 Gustave Roussy, Villejuif, France
2 Institut Galien Paris-Saclay, Orsay, France
Mapping of sterile anticancer drug preparations in hospital pharmacies in Nouvelle-Aquitaine: current status, territorial disparities and opportunities for cooperation N. Hami1,2, J. Azard2
1 Université de Bordeaux, 33000 Bordeaux, France
2 ARS Nouvelle-Aquitaine, Pôle Produits de santé, Pharmacie, Biologie, 33000 Bordeaux, France USP-NF packaging system suitability: a simple yet powerful tool for differentiating packaging performances in terms of water permeability A. Sury1, F. Marçon1,2
1 Centre Hospitalier Universitaire d’Amiens, Amiens, France
2 Université de Picardie Jules Verne, Laboratoire AGIR UR4294, Amiens, France
Development of a method for the quantification of bacterial endotoxins in parenteral vitamin-lipid emulsion preparations using the recombinant C factor O. Allard1, M. Barrieu2, J. Claves1, M. Jouannet1, P. Chennell2
1 CHU Clermont-Ferrand, Pôle Pharmacie, F-63003 Clermont-Ferrand, France
2 Université Clermont Auvergne, CHU Clermont Ferrand, Clermont Auvergne INP, CNRS, ICCF, F-63000 Clermont-Ferrand, France
E-Posters - Session A: Quality Assurance, Risk Analysis and CSR
Implementation of a Professional Practice Assessment within a nuclear pharmacy
E. De Landtsheer, G. Pariscoat, J. Legrand
APHP, Hôpital Bichat Claude-Bernard, Paris, France
Evaluation of a reception and thawing assistance tool for securing the Car-t Cells circuit C. Notteau1, L. Deramoudt1,2, M. Leroy1 ,A. Lecoutre1, J. Courtin1, M. Pinturaud1,2, M. Vasseur1,2, P. Odou1,2
1 Institut de Pharmacie, Centre Hospitalier Universitaire, Lille, France
2 Univ Lille, ULR 7365-GRITA, Lille, France
Reducing the air flow in a Chemotherapy Production Unit (CPU) during a period of rest without compromising environmental parameters during the activity in an eco- responsible approach. A. Le Gall, A. Glavieux, C. Melin
Centre Hospitalier de Périgueux, France Preliminary Risk Assessment of the Design of Facilities for the Preparation of Advanced Therapy Medicinal Products G. Ayari, N. Nicolas, C. Vallance
Institut de Cancérologie de Lorraine - Alexis Vautrin, Vandœuvre-lès-Nancy, France Non-sterile preparations: how to assess occupational risk for pharmacy technicians ? P. Bouquet, C. Lamour, V. Vincourt, A. Podvin
Centre Hospitalier de Douai, France Implementation of Datamatrix Codes on Vials: A Time-Saving Measure? M. Lac, A. Narwa, N. Raimundo, A. Merou, M. Soutera, P. Jeanselme, K. Leger, O. Civier, S. Ennebet, C. Guillemot, F. Puisset, S. Perriat, A. Martel
Pharmacy Department, IUCT Oncopole Conception and Evaluation of a regional tool for risk situations of errors or exposure related to the use of cytotoxics Z. Mellahi1, V. Massot1, Z. Leguay2, H. Du Portal3
1 Centre Hospitalier Régional Universitaire de Tours, France
2 Centre Hospitalier Universitaire d’Orléans, France
3 OMéDIT Centre-Val de Loire, Tours, France Qualification of Pharmaceutical Staff for Handling Cytotoxic Safety Cabinets: Simulation at the Heart of Certification L. Fourcaud, S. Hermann, G. Hily, D. Sankhare, N. Jourdan, I. Madelaine, M. Brault
Hôpital Saint-Louis (APHP), Paris, France
Continuing education of hospital pharmacy technicians in Cytotoxic Reconstitution Unit (CRU) a regional level answer: results of 4 CRUATHLON H. Bertucat1, L. Cantournet2, R. Chevrier3, A-C. Cholley4, S. Danjean5, A. Demaziere1, M. Etis6, M. Jouannet7, C. Lechevalier8, A. Peyrol9, S. Picandet10, S. Talavera-Pons11, S. Trevis7, C. Ragazzon12, A. Simand13, E. Sigward14
1 CH J. Lacarin Vichy, 2 CH Henri Mondor Aurillac, 3 Centre Jean Perrin Clermont Ferrand, 4 CH de Brioude, 5 CH de Moulins-Yzeure, 6 CH de Roanne, 7 CHU Clermont Ferrand, 8 CH de St-Flour, 9 CH d’Ambert, 10 Clinique St Francois Désertines, 11 CH de Thiers, 12 CH Emile Roux Puy en Velay, 13 Pole Santé République Clermont Ferrand, 14 CH de Montluçon, France.
Prospective Assessment of the Economic Implications of Automating Chemotherapy Preparation in a Comprehensive Cancer Center A. Maes, C. Mennetrier, S. Capron, F. Basuyau, J. Rouvet
Centre Henri Becquerel, Rouen, France “Save Patient B”. An Escape Game in a Cytotoxic Production Unit" J. Palluaud, C. Buet, M. Benmalek, L. Pagnot, B. Cortes, E. Dussossoy
Hospices Civils de Lyon, Groupement Hospitalier Nord, Hôpital de la Croix-Rousse, France
APHP, Hôpital Bichat Claude-Bernard, Paris, France
Evaluation of a reception and thawing assistance tool for securing the Car-t Cells circuit C. Notteau1, L. Deramoudt1,2, M. Leroy1 ,A. Lecoutre1, J. Courtin1, M. Pinturaud1,2, M. Vasseur1,2, P. Odou1,2
1 Institut de Pharmacie, Centre Hospitalier Universitaire, Lille, France
2 Univ Lille, ULR 7365-GRITA, Lille, France
Reducing the air flow in a Chemotherapy Production Unit (CPU) during a period of rest without compromising environmental parameters during the activity in an eco- responsible approach. A. Le Gall, A. Glavieux, C. Melin
Centre Hospitalier de Périgueux, France Preliminary Risk Assessment of the Design of Facilities for the Preparation of Advanced Therapy Medicinal Products G. Ayari, N. Nicolas, C. Vallance
Institut de Cancérologie de Lorraine - Alexis Vautrin, Vandœuvre-lès-Nancy, France Non-sterile preparations: how to assess occupational risk for pharmacy technicians ? P. Bouquet, C. Lamour, V. Vincourt, A. Podvin
Centre Hospitalier de Douai, France Implementation of Datamatrix Codes on Vials: A Time-Saving Measure? M. Lac, A. Narwa, N. Raimundo, A. Merou, M. Soutera, P. Jeanselme, K. Leger, O. Civier, S. Ennebet, C. Guillemot, F. Puisset, S. Perriat, A. Martel
Pharmacy Department, IUCT Oncopole Conception and Evaluation of a regional tool for risk situations of errors or exposure related to the use of cytotoxics Z. Mellahi1, V. Massot1, Z. Leguay2, H. Du Portal3
1 Centre Hospitalier Régional Universitaire de Tours, France
2 Centre Hospitalier Universitaire d’Orléans, France
3 OMéDIT Centre-Val de Loire, Tours, France Qualification of Pharmaceutical Staff for Handling Cytotoxic Safety Cabinets: Simulation at the Heart of Certification L. Fourcaud, S. Hermann, G. Hily, D. Sankhare, N. Jourdan, I. Madelaine, M. Brault
Hôpital Saint-Louis (APHP), Paris, France
Continuing education of hospital pharmacy technicians in Cytotoxic Reconstitution Unit (CRU) a regional level answer: results of 4 CRUATHLON H. Bertucat1, L. Cantournet2, R. Chevrier3, A-C. Cholley4, S. Danjean5, A. Demaziere1, M. Etis6, M. Jouannet7, C. Lechevalier8, A. Peyrol9, S. Picandet10, S. Talavera-Pons11, S. Trevis7, C. Ragazzon12, A. Simand13, E. Sigward14
1 CH J. Lacarin Vichy, 2 CH Henri Mondor Aurillac, 3 Centre Jean Perrin Clermont Ferrand, 4 CH de Brioude, 5 CH de Moulins-Yzeure, 6 CH de Roanne, 7 CHU Clermont Ferrand, 8 CH de St-Flour, 9 CH d’Ambert, 10 Clinique St Francois Désertines, 11 CH de Thiers, 12 CH Emile Roux Puy en Velay, 13 Pole Santé République Clermont Ferrand, 14 CH de Montluçon, France.
Prospective Assessment of the Economic Implications of Automating Chemotherapy Preparation in a Comprehensive Cancer Center A. Maes, C. Mennetrier, S. Capron, F. Basuyau, J. Rouvet
Centre Henri Becquerel, Rouen, France “Save Patient B”. An Escape Game in a Cytotoxic Production Unit" J. Palluaud, C. Buet, M. Benmalek, L. Pagnot, B. Cortes, E. Dussossoy
Hospices Civils de Lyon, Groupement Hospitalier Nord, Hôpital de la Croix-Rousse, France
E-Posters - Session B: Feasibility studies - Formulations
Optimization of the production of Gallium-68 labeled peptides (PSMA et DOTATOC)
J. Costes1, A. Pierrot1, K. Casagrande1, J. Masset2, J. Delage1, F. Sadeghipour1,3,4.
1 Pharmacy Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
2 Research and Development Center, Trasis Radiopharmacy Instruments, Ans, Belgium.
3 Pharmaceutical Sciences, Geneva-Lausanne Pharmacy School, University of Geneva, Switzerland.
4 Centre de Recherche et d’Innovations en Sciences Pharmaceutiques cliniques, University of Lausanne, Switzerland. Technical and regulatory feasibility of a new sterile preparation posing health and environmental risk: the case of 30% ethanol eye drops A-L. Dupart, C. De Lacroix, O. Foulon, G. Camus, A-L. Antoine
Pharmacie à usage intérieur, Hôpital national d’instruction des armées Percy, Clamart, France
Feasibility study: internal production and controls of autologous serum eyedrops (ASED) D. Clerice, L. Jemour, I. Girault, H. Perrier
Centre Hospitalier du Mans, Le Mans, France Development of an automatized production of 68Ga-FAPI-46 in an Hospital A. Pierrot1, K. Casagrande1, J. Costes1, J. Delage1, F. Sadeghipour2,3,4
1 Radiopharmacy Unit, Department of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, SWITZERLAND,
2 Department of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, SWITZERLAND,
3 Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, SWITZERLAND,
4 Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Lausanne, SWITZERLAND.
Feasibility study of centralizing biotherapy preparations at the Annecy Genevois Hospital Center R. Francis, C. Zecchini Prina, P. Lourman, G. Vary
PUI, Annecy Genevois Hospital Center Flocculation of etoposide preparations: what are the influencing factors? C. Martelet1, C. Lopes1, E.Baba1, L. Negrier1,2 C. Danel1, J. Courtin1, A. Lecoutre1, M. Vasseur1,2, P. Odou1,2 1 CHU Lille, Institut de pharmacie, 59000 Lille, France
2 Université de Lille, CHU Lille, ULR 7365 - GRITA - Groupe de recherche sur les formes injectables et les technologies associées, 59000 LILLE
Development of a new formulation for preparing oral provocation tests (OPT) for nuts in allergology J. Lahsinat, J. Bourbon, S. Doucet
Hôpitaux Civils de Colmar, France Identification of critical parameters for an automatic film applicator to produce orodispersible hydrocortisone hemisuccinate films L. Nobilet1, B. Toussaint1,2, M. Sauvat1, A. Thouvenin1,2, B. Andre-Nonque1, P. Lamarque3, E. De Landtsheer3, A. Schweitzer-Chaput3, V. Boudy1,2
1 Département de Recherche et Développement Pharmaceutique, AGEPS, APHP, Paris, France
2 UTCBS, CNRS, Inserm, Université Paris Cité, Paris, France
3 Pharmacie à Usage Intérieur, Hôpital Necker-Enfants Malades, APHP, Paris, France
3D Printing of Antiemetics: Rheology Serving Personalized Medicine R. Bodin, S. Ramos, M. Boucida, L. Denis, B. Do
Gustave Roussy, Villejuif, France
Qualification of the aseptic process for preparing 10%-5% glycerol-fructose bags Qualification of the aseptic process for preparing 10%-5% glycerol-fructose bags A. Megnounif, C. Baguet, P. Chapron, E. Olivier, N. Cormier
Pharmacie, Nantes Université, CHU, Nantes, France
1 Pharmacy Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
2 Research and Development Center, Trasis Radiopharmacy Instruments, Ans, Belgium.
3 Pharmaceutical Sciences, Geneva-Lausanne Pharmacy School, University of Geneva, Switzerland.
4 Centre de Recherche et d’Innovations en Sciences Pharmaceutiques cliniques, University of Lausanne, Switzerland. Technical and regulatory feasibility of a new sterile preparation posing health and environmental risk: the case of 30% ethanol eye drops A-L. Dupart, C. De Lacroix, O. Foulon, G. Camus, A-L. Antoine
Pharmacie à usage intérieur, Hôpital national d’instruction des armées Percy, Clamart, France
Feasibility study: internal production and controls of autologous serum eyedrops (ASED) D. Clerice, L. Jemour, I. Girault, H. Perrier
Centre Hospitalier du Mans, Le Mans, France Development of an automatized production of 68Ga-FAPI-46 in an Hospital A. Pierrot1, K. Casagrande1, J. Costes1, J. Delage1, F. Sadeghipour2,3,4
1 Radiopharmacy Unit, Department of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, SWITZERLAND,
2 Department of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, SWITZERLAND,
3 Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, SWITZERLAND,
4 Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Lausanne, SWITZERLAND.
Feasibility study of centralizing biotherapy preparations at the Annecy Genevois Hospital Center R. Francis, C. Zecchini Prina, P. Lourman, G. Vary
PUI, Annecy Genevois Hospital Center Flocculation of etoposide preparations: what are the influencing factors? C. Martelet1, C. Lopes1, E.Baba1, L. Negrier1,2 C. Danel1, J. Courtin1, A. Lecoutre1, M. Vasseur1,2, P. Odou1,2 1 CHU Lille, Institut de pharmacie, 59000 Lille, France
2 Université de Lille, CHU Lille, ULR 7365 - GRITA - Groupe de recherche sur les formes injectables et les technologies associées, 59000 LILLE
Development of a new formulation for preparing oral provocation tests (OPT) for nuts in allergology J. Lahsinat, J. Bourbon, S. Doucet
Hôpitaux Civils de Colmar, France Identification of critical parameters for an automatic film applicator to produce orodispersible hydrocortisone hemisuccinate films L. Nobilet1, B. Toussaint1,2, M. Sauvat1, A. Thouvenin1,2, B. Andre-Nonque1, P. Lamarque3, E. De Landtsheer3, A. Schweitzer-Chaput3, V. Boudy1,2
1 Département de Recherche et Développement Pharmaceutique, AGEPS, APHP, Paris, France
2 UTCBS, CNRS, Inserm, Université Paris Cité, Paris, France
3 Pharmacie à Usage Intérieur, Hôpital Necker-Enfants Malades, APHP, Paris, France
3D Printing of Antiemetics: Rheology Serving Personalized Medicine R. Bodin, S. Ramos, M. Boucida, L. Denis, B. Do
Gustave Roussy, Villejuif, France
Qualification of the aseptic process for preparing 10%-5% glycerol-fructose bags Qualification of the aseptic process for preparing 10%-5% glycerol-fructose bags A. Megnounif, C. Baguet, P. Chapron, E. Olivier, N. Cormier
Pharmacie, Nantes Université, CHU, Nantes, France
E-Posters - Session C: Stability studies and quality control
Training and qualification in the visual inspection and labelling of hospital-compounded eye drops
J. Prud’homme, H. Briche, A. Kalinowski, M.-L. Brandely-Piat, M. Jobard, R. Batista
APHP, Hôpital Cochin, Paris, France Case of non-compliant eye drops: investigation on non visible particles E. Tireau, K. Lefevre, V. Lebreton, S. Vrignaud
Centre Hospitalier Universitaire Angers, France Container-content interactions tests for automated dispensing of radiopharmaceuticals : who’s gonna stick to it? M. Delion, R. Boquet, C. Schmitt, O. Madar, J. Fouque
Institut Curie, Saint Cloud, France
Sterility testing of aqueous and oily eye drops using the Bactec® automated system: feasibility and validation C. Ankidine, L. Bourgue, Y.-P. Yemi, M. Ben Reguiga
Centre Hospitalier de Mayotte, France Paclitaxel desensitization protocol: stability study C. Mathieu1, A. Pinard1,2, F. Pham1, H. Doillet1, S. Poullain1
1 Centre Hospitalier Intercommunal de Créteil, France
2 APHP, Hôpital Henri Mondor, Créteil, France Physico-chemical stability of ceftazidime fortified eye drops 20 mg/mL stored at -20°C G. Loeuille, S. Brafine, M. Paulin, K. Nasraoui, S. Ruster, C. Padoin
University Hospital of Martinique, Fort-de-France, France Stability study of several insulins in a binary parenteral nutrition mixture. T. Ternel1,2, C. Foulon1, M. Kouach1, T. Dine1, H. Henry1,2, P. Odou1,2
1 Univ. Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France
2 CHU Lille, Institut de pharmacie, F-59000 Lille, France
Comparative Study of Content Uniformity Between Capsules and 3D-Printed Oral Forms Manufactured by Semi-Solid Extrusion L. Lemierrea,b, D. Stefanellia, S. Roulona, R. Mazet c, C. Curti d, I. Soulairola,b,e
a MB Therapeutics, Montpellier, France
b ICGM, University of Montpellier, CNRS, ENSCM, Montpellier, France
c Pharmacy Department, CHU Grenoble Alpes, Grenoble, France
d Pharmacy Department, APHM, Marseille, France
e Pharmacy Department, CHU de Nîmes, Nîmes, France
Implementation of a protocol to induce tolerance to nirogacestat in a responder patient: stability of a drinkable liquid form O. Nowak1, A. Lavergne1, C. Coumes-Salomon2, V. Le-Brun-Ly2, S. Dulaurent2, N. Picard2, V. Ratsimbazafy2
1 Université de Pharmacie de Limoges, France
2 Centre Hospitalier Universitaire de Limoges, France Microbiological stability of a 10 µg/mL clonidine solution for paediatric use C. Ranza, C. Fanjeaux, R. Vazquez, M-N. Guerrault-Moro
Centre Hospitalier Intercommunal de Poissy St-Germain-en-Laye, France
APHP, Hôpital Cochin, Paris, France Case of non-compliant eye drops: investigation on non visible particles E. Tireau, K. Lefevre, V. Lebreton, S. Vrignaud
Centre Hospitalier Universitaire Angers, France Container-content interactions tests for automated dispensing of radiopharmaceuticals : who’s gonna stick to it? M. Delion, R. Boquet, C. Schmitt, O. Madar, J. Fouque
Institut Curie, Saint Cloud, France
Sterility testing of aqueous and oily eye drops using the Bactec® automated system: feasibility and validation C. Ankidine, L. Bourgue, Y.-P. Yemi, M. Ben Reguiga
Centre Hospitalier de Mayotte, France Paclitaxel desensitization protocol: stability study C. Mathieu1, A. Pinard1,2, F. Pham1, H. Doillet1, S. Poullain1
1 Centre Hospitalier Intercommunal de Créteil, France
2 APHP, Hôpital Henri Mondor, Créteil, France Physico-chemical stability of ceftazidime fortified eye drops 20 mg/mL stored at -20°C G. Loeuille, S. Brafine, M. Paulin, K. Nasraoui, S. Ruster, C. Padoin
University Hospital of Martinique, Fort-de-France, France Stability study of several insulins in a binary parenteral nutrition mixture. T. Ternel1,2, C. Foulon1, M. Kouach1, T. Dine1, H. Henry1,2, P. Odou1,2
1 Univ. Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France
2 CHU Lille, Institut de pharmacie, F-59000 Lille, France
Comparative Study of Content Uniformity Between Capsules and 3D-Printed Oral Forms Manufactured by Semi-Solid Extrusion L. Lemierrea,b, D. Stefanellia, S. Roulona, R. Mazet c, C. Curti d, I. Soulairola,b,e
a MB Therapeutics, Montpellier, France
b ICGM, University of Montpellier, CNRS, ENSCM, Montpellier, France
c Pharmacy Department, CHU Grenoble Alpes, Grenoble, France
d Pharmacy Department, APHM, Marseille, France
e Pharmacy Department, CHU de Nîmes, Nîmes, France
Implementation of a protocol to induce tolerance to nirogacestat in a responder patient: stability of a drinkable liquid form O. Nowak1, A. Lavergne1, C. Coumes-Salomon2, V. Le-Brun-Ly2, S. Dulaurent2, N. Picard2, V. Ratsimbazafy2
1 Université de Pharmacie de Limoges, France
2 Centre Hospitalier Universitaire de Limoges, France Microbiological stability of a 10 µg/mL clonidine solution for paediatric use C. Ranza, C. Fanjeaux, R. Vazquez, M-N. Guerrault-Moro
Centre Hospitalier Intercommunal de Poissy St-Germain-en-Laye, France
E-Posters - Session D: Production and automation processes
No safety net in pharmaceutical technology: How the absence of continuous service affects hospital practice?
G. Baroux, A. Jalabert, A. Quintard, M. Cosson
Centre Hospitalier Universitaire de Montpellier, France Optimization of repackaging practices for solid oral forms M. Vicart, C. Senis loiseau, M. Khadimallah, C. Gransard, C. Floret
Centre Hospitalier de Béthune Beuvry, France Continuity of cancer treatment preparation : what resources are available at the regional level? C. Miniot1, H. Brillard2, C. Le Deroff-Poupeau1, N. Cassou2
1 OMEDIT Bretagne, Quimper, France
2 Pharmacie à Usage Intérieur, CH de Cornouaille, Quimper, France Cytotoxic drugs on the loose: alert, prevention, action! C. Morel, S. Muhammad, A. Brian, F. Bordet, M.-L. Maëstroni
Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France Robustness Evaluation of a Semi-Solid Extrusion 3D Printing Process for Oral Dosage Forms: A Case Study with Melatonin L. Lemierre1,2 , D. Stefanelli1 , S. Roulon1 , I. Soulairol1,2,3 1 MB Therapeutics, Montpellier, France
2 ICGM, Université de Montpellier, CNRS, ENSCM, Montpellier, France
3 Département de pharmacie, CHU de Nîmes, Nîmes, France
Qualification of Biocleaning in Cleanrooms L. Ciarlitti1, M. Cristofoli1, N. Malié, 1A. Bensahkoun1, C. Marchand1, B. Lapras1, C. Merienne1, F. Pirot1,2
1 Hospices Civils de Lyon, Groupement Hospitalier Edouard Herriot, Lyon, France
2 Université Claude Bernard Lyon-1, Faculté de Pharmacie de Lyon, Laboratoire de Biologie tissulaire et Ingénierie Thérapeutique UMR-CNRS 5305, France Validation of an automated method for cyclophosphamide reconstitution and comparison with the manual process E. Roulleau, B. Mathat, E. Clapeau, A. Goubil, C. Fronteau, V. Laurent, C. Baguet, N. Cormier
Pharmacy unit, University Hospital of Nantes, France Gallium radioactive labelling using radionuclide generators from different suppliers T. Bataillard, L. Cougourdan, E. Mordefroy, O. Angoue
Centre Hospitalier Universitaire Jean Minjoz, Besançon, France Microbiological qualification of a robot, Kiro Isolator® (Grifols), for the preparation of anticancer chemotherapies J. Guehenneux, A. Delépine, R. Desmaris, M. Friou
Institut Curie, Saint-Cloud, France One ATMP, Two Hospital Pharmacies, No Compromise A. Barusseau1, A. Brun-Fitton1, A. Brouard1, B. Quélennec1, M.-A. Lester2, A. Jouvance-Le Bail2, A. Chérel1
1 : Service Pharmacie, Groupe Hospitalier Bretagne Sud, 5 avenue de Choiseul, 56100 Lorient, France
2 : Pharmacie, CHU de Rennes, 2 Rue Henri Le Guilloux, 35000 Rennes, France
Cytotoxic Agents: Breaking to Manage Better! C. Communier, F. Gaume, F. Ou Cebron, C. Airiau
Centre Hospitalier de Cholet, France
Centre Hospitalier Universitaire de Montpellier, France Optimization of repackaging practices for solid oral forms M. Vicart, C. Senis loiseau, M. Khadimallah, C. Gransard, C. Floret
Centre Hospitalier de Béthune Beuvry, France Continuity of cancer treatment preparation : what resources are available at the regional level? C. Miniot1, H. Brillard2, C. Le Deroff-Poupeau1, N. Cassou2
1 OMEDIT Bretagne, Quimper, France
2 Pharmacie à Usage Intérieur, CH de Cornouaille, Quimper, France Cytotoxic drugs on the loose: alert, prevention, action! C. Morel, S. Muhammad, A. Brian, F. Bordet, M.-L. Maëstroni
Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France Robustness Evaluation of a Semi-Solid Extrusion 3D Printing Process for Oral Dosage Forms: A Case Study with Melatonin L. Lemierre1,2 , D. Stefanelli1 , S. Roulon1 , I. Soulairol1,2,3 1 MB Therapeutics, Montpellier, France
2 ICGM, Université de Montpellier, CNRS, ENSCM, Montpellier, France
3 Département de pharmacie, CHU de Nîmes, Nîmes, France
Qualification of Biocleaning in Cleanrooms L. Ciarlitti1, M. Cristofoli1, N. Malié, 1A. Bensahkoun1, C. Marchand1, B. Lapras1, C. Merienne1, F. Pirot1,2
1 Hospices Civils de Lyon, Groupement Hospitalier Edouard Herriot, Lyon, France
2 Université Claude Bernard Lyon-1, Faculté de Pharmacie de Lyon, Laboratoire de Biologie tissulaire et Ingénierie Thérapeutique UMR-CNRS 5305, France Validation of an automated method for cyclophosphamide reconstitution and comparison with the manual process E. Roulleau, B. Mathat, E. Clapeau, A. Goubil, C. Fronteau, V. Laurent, C. Baguet, N. Cormier
Pharmacy unit, University Hospital of Nantes, France Gallium radioactive labelling using radionuclide generators from different suppliers T. Bataillard, L. Cougourdan, E. Mordefroy, O. Angoue
Centre Hospitalier Universitaire Jean Minjoz, Besançon, France Microbiological qualification of a robot, Kiro Isolator® (Grifols), for the preparation of anticancer chemotherapies J. Guehenneux, A. Delépine, R. Desmaris, M. Friou
Institut Curie, Saint-Cloud, France One ATMP, Two Hospital Pharmacies, No Compromise A. Barusseau1, A. Brun-Fitton1, A. Brouard1, B. Quélennec1, M.-A. Lester2, A. Jouvance-Le Bail2, A. Chérel1
1 : Service Pharmacie, Groupe Hospitalier Bretagne Sud, 5 avenue de Choiseul, 56100 Lorient, France
2 : Pharmacie, CHU de Rennes, 2 Rue Henri Le Guilloux, 35000 Rennes, France
Cytotoxic Agents: Breaking to Manage Better! C. Communier, F. Gaume, F. Ou Cebron, C. Airiau
Centre Hospitalier de Cholet, France
E-Posters - Session E: Analytical and microbiological techniques
Physicochemical Validation of the Sterile Filtration Process for Hospital-Compounded Gentamicin Eye Drops
G. Sayet, S. Bansart, V. Delplanque, M-G. Philipot, M-C. Despiau
Hôpital National de la vision, Paris, France Validation of a stability-indicating assay method for epalrestat using UV detection high-performance liquid chromatography V. Raffet, I. Palmieri, P. Marchadour, C. Cotteret, A. Schweitzer-Chaput
APHP, Hôpital Necker-Enfants Malades, Paris Characterisation of polymer films for intravenous solvent bags packaging C. Hosotte, L. Carrez, F. Sadeghipour
Centre Hospitalier Universitaire Vaudois, Lausanne, Suisse
Development of a gamma counter calibration protocol for radiopharmaceutical applications E. Oger, L. Guiheneuc, M. Bourgeois
Centre Hospitalier Universitaire de Nantes, France Method Development for the Quantification of Erythromycin in 250 mg Capsules I. Palmieri, V. Raffet, P. Marchadour, R. Ratiney, C. Cotteret, A. Schweitzer-Chaput
Department of Pharmacy, AP-HP, Necker Hospital, Paris, France. A blood gas analyzer for parenteral nutrition bags analysis? Performance evaluation and method validation K. Tlili, N. Chaoui, A. Diallo, X. Deviot
Centre Hospitalier de Saint-Denis, France Analytical Control by UV Spectrophotometry with DRUGLOG®: Relevance for In-House Calibration Ranges? N. Salama, T. Tang, S. Belhadj, H. Smati, S. Blondeel-Gomes, L. Bisseux, F. El Kouari
Pharmacy Department, GHI Le Raincy-Montfermeil, France Development and Validation of the Sterility Test for a New 1mg/mL Ropivacaine Preparation C. Auriault, C. Baguet, P. Chapron, N. Humeau, F. Bellabiod, S. Guernier, E. Olivier, N. Cormier
Centre Hospitalier Universitaire de Nantes, France Développement et validation de l’essai de stérilité pour une nouvelle préparation de ropivacaïne à 1 mg/mL C. Auriault, C. Baguet, P. Chapron, N. Humeau, F. Bellabiod, S. Guernier, E. Olivier, N. Cormier
Centre Hospitalier Universitaire de Nantes, France Development and Validation of the Sterility Test for a New 1mg/mL Ropivacaine Preparation C. Auriault, C. Baguet, P. Chapron, N. Humeau, F. Bellabiod, S. Guernier, E. Olivier, N. Cormier
Centre Hospitalier Universitaire de Nantes, France
Hôpital National de la vision, Paris, France Validation of a stability-indicating assay method for epalrestat using UV detection high-performance liquid chromatography V. Raffet, I. Palmieri, P. Marchadour, C. Cotteret, A. Schweitzer-Chaput
APHP, Hôpital Necker-Enfants Malades, Paris Characterisation of polymer films for intravenous solvent bags packaging C. Hosotte, L. Carrez, F. Sadeghipour
Centre Hospitalier Universitaire Vaudois, Lausanne, Suisse
Development of a gamma counter calibration protocol for radiopharmaceutical applications E. Oger, L. Guiheneuc, M. Bourgeois
Centre Hospitalier Universitaire de Nantes, France Method Development for the Quantification of Erythromycin in 250 mg Capsules I. Palmieri, V. Raffet, P. Marchadour, R. Ratiney, C. Cotteret, A. Schweitzer-Chaput
Department of Pharmacy, AP-HP, Necker Hospital, Paris, France. A blood gas analyzer for parenteral nutrition bags analysis? Performance evaluation and method validation K. Tlili, N. Chaoui, A. Diallo, X. Deviot
Centre Hospitalier de Saint-Denis, France Analytical Control by UV Spectrophotometry with DRUGLOG®: Relevance for In-House Calibration Ranges? N. Salama, T. Tang, S. Belhadj, H. Smati, S. Blondeel-Gomes, L. Bisseux, F. El Kouari
Pharmacy Department, GHI Le Raincy-Montfermeil, France Development and Validation of the Sterility Test for a New 1mg/mL Ropivacaine Preparation C. Auriault, C. Baguet, P. Chapron, N. Humeau, F. Bellabiod, S. Guernier, E. Olivier, N. Cormier
Centre Hospitalier Universitaire de Nantes, France Développement et validation de l’essai de stérilité pour une nouvelle préparation de ropivacaïne à 1 mg/mL C. Auriault, C. Baguet, P. Chapron, N. Humeau, F. Bellabiod, S. Guernier, E. Olivier, N. Cormier
Centre Hospitalier Universitaire de Nantes, France Development and Validation of the Sterility Test for a New 1mg/mL Ropivacaine Preparation C. Auriault, C. Baguet, P. Chapron, N. Humeau, F. Bellabiod, S. Guernier, E. Olivier, N. Cormier
Centre Hospitalier Universitaire de Nantes, France
GERPAC
Association Loi 1901
Siège social : Chez Jean-Yves Jomier / 8ter rue Léon Bussat, 64000 PAU
Immatriculation formation N° 72 64 035 30 64
Contact us Legal notes - Management of personal data